'Benign' malaria key driver of human evolution in Asia-PacificSeptember 04, 2012
Their finding challenges the widely-accepted theory that Plasmodium falciparum, which causes the most lethal form of malaria, is the only malaria parasite capable of driving genome evolution in humans. The study was published today in the journal PLOS Medicine.
Professor Ivo Mueller from the Walter and Eliza Hall Institute and Barcelona Centre for International Health Research (CRESIB) led the study, with colleagues from the Papua New Guinea Institute of Medical Research, Centre of Global Health and Diseases, US, and the University of Western Australia.
Malaria is a devastating parasitic disease that kills up to one million people a year. It is a major cause of poverty and a barrier to economic development. Approximately half of the world's population is at risk of malaria infection.
"Humans and malaria parasites have been co-evolving for thousands of years," Professor Mueller said. "Malaria has been a major force in the evolution of the human genome, with gene mutations that provide humans with some protection against the disease being preserved through natural selection because they aid in survival."
Professor Mueller said the study has challenged the perception that P. falciparum malaria is the only malaria species that affects human genome evolution. "It has long been assumed that Plasmodium falciparum, the species that causes the most severe disease and most deaths from malaria, is the most important driver of this gene selection in humans," Professor Mueller said. "Our results suggest that P. vivax malaria, though until recently widely considered to be a 'benign' form of malaria, actually causes severe enough disease to provide evolutionary selection pressures in the Asia-Pacific."
Professor Mueller said that the research team was interested in whether P. vivax malaria might be the cause of the unusually high rates of Southeast Asian ovalocytosis (SAO), a hereditary red blood cell disorder, in the Asia-Pacific region. "SAO occurs in approximately 10 to 15 per cent of the population in parts of the South West Pacific and is caused by a hereditary mutation in a single copy of a gene that makes a red blood cell membrane protein. This is almost an absurdly high frequency when you consider that inheriting two copies of the mutation is invariably fatal, so we figured it must confer a strong advantage to the carriers," he said.
The research team looked at the incidence of P. vivax and P. falciparum infections in three studies that included a total of 1975 children in Papua New Guinea aged 0-14 years. "We found that SAO-positive children were significantly protected against P. vivax infection, with 46 per cent reduction of clinical disease in infants with little or no immunity, and 52-55 per cent reduction in the risk of infection in older children. We also saw a significant decrease in parasite numbers in infants and older children, which is linked to a decrease in risk of clinical disease," Professor Mueller said.
The finding could have dramatic implications for future malaria vaccine design and development, Professor Mueller said. "Studying the mechanisms that cause SAO-positive people to be protected against P. vivax malaria could help us to better understand the mechanics of infection and help us to identify better targets for a malaria vaccine," he said.
Walter and Eliza Hall Institute
Related Malaria Articles:
Malaria is a global killer and a world health concern.
Scientists have discovered a gene that allows to double the production of artemisinin in the Artemisia annua plant.
EPFL scientists have fully modeled the metabolism of the deadliest malaria parasite.
Should we commit to eradicate malaria worldwide, asks a debate article published by The BMJ today?
An investigational malaria vaccine given intravenously was well-tolerated and protected a significant proportion of healthy adults against infection with Plasmodium falciparum malaria -- the deadliest form of the disease -- for the duration of the malaria season, according to new findings published in the Feb.
Malaria mosquitoes prefer to feed -- and feed more -- on blood from people infected with malaria.
A lineage of multidrug resistant P. falciparum malaria superbugs has widely spread and is now established in parts of Thailand, Laos and Cambodia, causing high treatment failure rates for the main falciparum malaria medicines, artemisinin combination therapies (ACTs), according to a study published today in The Lancet Infectious Diseases.
The goal of eliminating malaria in countries like India could be more achievable if mosquito-control efforts take into account the relationship between mosquitoes and cattle, according to an international team of researchers.
Giving preventive antimalarial drugs to children up to age 10 during active malaria season reduced the cases of malaria in that age group and lowered the malaria incidence in adults, according to a randomized trial carried out in Senegal and published in PLOS Medicine by researchers from the Université Cheikh Anta Diop, Senegal, the London School of Hygiene & Tropical Medicine, UK, and other collaborators.
OIST researchers reconstruct the 3-D structure of a malaria protein in combination with human antibodies.
Related Malaria Reading:
The Fever: How Malaria Has Ruled Humankind for 500,000 Years
by Sonia Shah (Author)
In recent years, malaria has emerged as a cause celebre for voguish philanthropists. Bill Gates, Bono, and Laura Bush are only a few of the personalities who have lent their names--and opened their pocketbooks--in hopes of stopping the disease. Still, in a time when every emergent disease inspires waves of panic, why aren't we doing more to tame one of our oldest foes? And how does a pathogen that we've known how to prevent for more than a century still infect 500 million people every year, killing nearly one million of them?
In The Fever, journalist Sonia Shah sets out to answer those... View Details
The Making of a Tropical Disease: A Short History of Malaria (Johns Hopkins Biographies of Disease)
by Randall M. Packard (Author)
Malaria sickens hundreds of millions of people―and kills one to three million―each year. Despite massive efforts to eradicate the disease, it remains a major public health problem in poorer tropical regions. But malaria has not always been concentrated in tropical areas. How did other regions control malaria and why does the disease still flourish in some parts of the globe?
From Russia to Bengal to Palm Beach, Randall Packard’s far-ranging narrative traces the natural and social forces that help malaria spread and make it deadly. He finds that war, land development, crumbling... View Details
The Malaria Project: The U.S. Government's Secret Mission to Find a Miracle Cure
by Karen M. Masterson (Author)
A shocking exposé of America’s secret mission to combat malaria during World War II with a campaign that tested experimental drugs on men gone mad from syphilis.
Foreseeing the need for a malaria drug, American war planners re-created Germany’s research model, then grew it tenfold. Spearheading the effort, Dr. Lowell T. Coggeshall recruited private corporations as well as chemists from Harvard and Johns Hopkins to make novel compounds, which were then tested on human subjects.
By 1943, a dozen strains of malaria were injected into mental health patients and convicted... View Details
The Conquest of Malaria: Italy, 1900-1962
by Frank Snowden (Author)
At the outset of the twentieth century, malaria was Italy’s major public health problem. It was the cause of low productivity, poverty, and economic backwardness, while it also stunted literacy, limited political participation, and undermined the army. In this book Frank Snowden recounts how Italy became the world center for the development of malariology as a medical discipline and launched the first national campaign to eradicate the disease.
Snowden traces the early advances, the setbacks of world wars and Fascist dictatorship, and the final victory against malaria after World... View Details
Malaria Dreams: An African Adventure
by Stuart Stevens (Author)
Introducing the life cycles of the main animal groups, this series provides an overview of key physical characteristics and covers the life cycle from birth, or hatching, to death, looking at growing up, feeding, mating, keeping safe, threats and survival. Each title includes simple charts and graphs to explain patterns of change and compare offspring to parent from a wide range of animal examples from near home and around the world. View Details
Malaria (Diseases and Disorders)
by Melissa Abramovitz (Author)
Book by Abramovitz, Melissa View Details
First Comes Love, then Comes Malaria: How a Peace Corps Poster Boy Won My Heart and a Third World Adventure Changed My Life
by Eve Brown-Waite (Author)
“Eve Brown-Waite writes as she lives – with verve and humor and a fine sense of the absurd.” -- Martin Troost, author of Lost on Planet China
Eve Brown’s dream is to join the Peace Corps … and maybe solve world hunger and win a Nobel Peace Prize along the way. But she secretly fears she isn’t tough enough to survive the bug-infested jungle, much less life without toilet paper and decaf cappuccino. Then she falls head-over-little-black-heels in love with John--a dashing Peace Corps recruiter whose do-gooder passions outshine her own. She becomes more... View Details
Malaria: Super Killer! (Nightmare Plagues)
by Stephen Person (Author)
One of the oldest diseases in history, malaria was once common all over the world. Some scientists believe that malaria may have killed more people than any other disease in human history. Fortunately, doctors now understand the causes of the disease and have developed effective treatments. Yet in some parts of the world, malaria continues to kill hundreds of thousands of people each year. In fact, its estimated that every 30 seconds a child in Africa dies from this terrible disease. Why is this super killer still taking so many lives? And will humans ever conquer malaria once and for all? In... View Details
Malaria (History of Germs)
by Jim Ollhoff (Author)
- Full-color Photographs
- Table of Contents
- Historical Photos
- Scientific Diagrams & Illustrations
- Maps View Details
PLAQUENIL Tablet: Prevents and Treats Acute Attacks of Malaria; and also Used to Treat Lupus and Rheumatoid Arthritis
by James Lee Anderson (Author)
“Although, your health condition may impact your everyday life, do not let it define who you are.” PLAQUENIL (hydroxychloroquine) is used to prevent and to treat malaria and to treat some conditions such as liver disease caused by protozoa. It is also used in the treatment of arthritis to help relieve inflammation, swelling, stiffness, and joint pain and to help control the symptoms of lupus erythematosus (lupus; SLE). Hydroxychloroquine belongs to the family of medicines called antiprotozoals. Protozoa are tiny, one-celled animals. Some are parasites that can cause many different kinds... View Details